Tag: MORT
COVID-19 Positivity Lower for Some With Psychiatric Disorders
Patients with schizophrenia, mood disorders, anxiety disorders have increased odds of COVID-19 mortality
Sacubitril-Valsartan Does Not Cut Risk for Death, Heart Failure After MI
Sacubitril-valsartan not linked to reduced incidence of death from cardiovascular causes or incident heart failure versus ramipril
Risk for Stillbirth Elevated for Deliveries With COVID-19
Adjusted relative risk for stillbirth higher in deliveries with COVID-19 in pre-delta and delta periods, with stronger link during delta period
ICU Bed Occupancy During COVID-19 Linked to Increase in Excess Deaths
If ICU bed use reached 75 percent capacity nationwide, an excess of 12,000 deaths would be expected two weeks later
Fewer Deaths Reported With Enrollment in COVID-19 Remote Monitoring
Remote monitoring service, COVID Watch, reduced deaths at 30 and 60 days and was associated with presentation to emergency department sooner
Prior Bariatric Surgery May Protect Against Severe COVID-19 Outcomes
Among COVID-19-positive adults, outcomes better for those with prior bariatric surgery versus those eligible for bariatric surgery
Smoking Linked to Fatal Event as First Sign of CVD
Smoking associated with earlier onset of cardiovascular disease, by 5.1 years for men and 3.8 years for women
Liver Transplant Outcomes Worse for Nonoverweight NAFLD Patients
Outcomes worse before and after liver transplant for nonoverweight versus overweight/obese adults with nonalcoholic fatty liver disease
SSRIs Linked to Reduced Relative Risk for Mortality in COVID-19
Relative risks for mortality significantly reduced for any SSRI, fluoxetine, and fluoxetine or fluvoxamine
Therapeutic Heparin May Benefit Moderately Ill COVID-19 Inpatients
Among those with increased D-dimer levels, no reduction seen in primary composite outcome at 28 days, but odds of death decreased
